Subscribe To
Eur/usd forex signal: hammer pattern points to brief rebound
Bullish view Buy the eur/usd pair and set a take-profit at 1.0830. Add a stop-loss at 1.0675. Bearish view Sell … Read Full Story at source (may req...
May 31, 2023, 9:14 am
Logicmark to participate in the healthcare it virtual conference part ii presented by maxim group llc and hosted by m-vest on thursday, june 1st
LOUISVILLE, Ky., May 31, 2023 (GLOBE NEWSWIRE) -- LogicMark, Inc. (Nasdaq: LGMK), creator of the most innovative personal safety and security technolo...
May 31, 2023, 9:00 am
Algernon pharmaceuticals receives notice of allowance from japanese patent office for repirinast
Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said it has received a Notice of Allowance from the Japanese ...
May 31, 2023, 8:34 am
Mynaric announces management participation in upcoming investor conferences
MUNICH, GERMANY / ACCESSWIRE / May 31, 2023 / Mynaric (NASDAQ:MYNA)(FRA:M0YN) today announced that management will partici...
May 31, 2023, 8:30 am
Aud/usd price analysis: bears resume amid poor chinese data
The Australian dollar declined due to a surprise deterioration in Chinese factory activity. In April, Australian consumer prices rose more than antici...
May 31, 2023, 8:14 am
Eur/jpy daily outlook
Daily Pivots: (S1) 149.66; (P) 150.14; (R1) 150.55; More…. Intraday bias in EUR/JPY remains neutral at this point. On the downside, break of 148.83 ...
May 31, 2023, 8:13 am
Jasper’s market squawk 31-05-2023
Dollar Down Despite Increasing Fed Hike Prospects The dollar slid lower in the first full day of trading despite expectations for another rate hike ri...
May 31, 2023, 8:11 am
Ardelyx to present at the jefferies 2023 healthcare conference
WALTHAM, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop...
May 31, 2023, 8:00 am
Eur/chf daily outlook
Daily Pivots: (S1) 0.9689; (P) 0.9707; (R1) 0.9742; More… Intraday bias in EUR/CHF remains neutral first. Strong support is still expected around 61...
May 31, 2023, 7:59 am
Ellington financial and arlington asset investment to merge, m&a arbitrage play
Ellington Financial announced a definitive stock and cash merger agreement with Arlington Asset Investment Corp., offering numerous benefits to both c...
May 31, 2023, 7:54 am
Usd/cad daily outlook
Daily Pivots: (S1) 1.3574; (P) 1.3594; (R1) 1.3619; More…. Intraday bias in USD/CAD remains neutral for the moment and outlook is unchanged. Price a...
May 31, 2023, 7:12 am
Caremax to present at the jefferies healthcare conference
MIAMI--(BUSINESS WIRE)--CareMax, Inc. (“CareMax”) (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, ann...
May 31, 2023, 6:55 am
Century lithium: patience required
Century Lithium recently reaffirmed its ability to produce battery-grade lithium, but further delayed the feasibility study completion for its Clayton...
May 31, 2023, 6:41 am
Morning star candlestick pattern: trading rules
A morning star pattern on a candlestick chart signals a bullish reversal. In this article, we will tell...
May 31, 2023, 6:31 am
Trane technologies to present at the ubs global industrials and transportation conference 2023
SWORDS, Ireland--(BUSINESS WIRE)--Trane Technologies plc (NYSE: TT) a global climate innovator, today announced that company leadership will partici...
May 31, 2023, 6:30 am
Why did venice canal turn bright green?
A patch of phosphorescent green liquid that appeared in Venice's Grand Canal was caused by the chemical...
May 31, 2023, 6:21 am
Volkswagen won't participate in china discount battle "at any price" - coo
Volkswagen will not participate in a discount battle in China "at any price", Chief Operating Officer R...
May 31, 2023, 3:49 am
European central bank president lagarde speaks wednesday, visco also
This first up from the European Central Bank today at 0800 GMT/ 0400 US Eastern time, Stability report:Then:0830 GMT/04:30 US Eastern time: Bank of It...
May 31, 2023, 3:17 am
Biomx to present part 1 data from phase 1b/2a study evaluating bx004 for the treatment of chronic pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis during late-breaking scie
CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 31, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clini...
May 31, 2023, 3:00 am
Biomx to present part 1 data from phase 1b/2a study evaluating bx004 for the treatment of chronic pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis during late-breaking scie
CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 31, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clini...
May 31, 2023, 3:00 am